Vanguard reports 5.11% stake in Vericel (2.60M sh)
Vericel Corp reports institutional ownership disclosure by Vanguard Capital Management.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vericel Corp reports institutional ownership disclosure by Vanguard Capital Management. Vanguard Capital Management states it beneficially owns 2,603,128 shares of Common Stock, representing 5.11% of the class. The filing shows sole voting power for 372,372 shares and sole dispositive power for 2,603,128 shares, with holdings held on behalf of various Vanguard affiliates and client accounts.
Insights
Vanguard reports a 5.11% beneficial stake in Vericel (2,603,128 shares).
Vanguard Capital Management files a Schedule 13G showing beneficial ownership of 2,603,128 shares, equal to 5.11% of Vericel common stock. The filing lists dispositive authority across Vanguard funds and related affiliates.
Holdings include sole voting power for 372,372 shares; cash‑flow treatment and trading intent are not disclosed in the excerpt. Subsequent filings would show any changes in stake or voting arrangements.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned regulatory
Sole dispositive power financial
Sole voting power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management report in Vericel (VCEL)?
How much voting power does Vanguard have in Vericel?
Who signed the Schedule 13G for Vanguard Capital Management?
AI-generated analysis. How Rhea-AI works. Not financial advice.